PSMA-TARGETED ACTIVATED MYELOID CELLS AS A NOVEL PROSTATE CANCER IMMUNOTHERAPY.

$1,228,125FY2021Department of the ArmyDOD

The Johns Hopkins University

Investigators

PSMA-TARGETED ACTIVATED MYELOID CELLS AS A NOVEL PROSTATE CANCER IMMUNOTHERAPY. · GrantIndex